feed,title,long_url,short_url
🔐MarketWatch,Dow Jones Newswires: Roche’s Tecentriq shows further good survival rates as cancer treatment,http://www.marketwatch.com/news/story.asp?guid=%7B20C0C4D5-7425-4434-F126-642DC55785F6%7D&siteid=rss&rss=1,https://da.gd/mEAHV
